1. "If you want to go far, go together". (22nd August 2017) Authors: Aplin, Andrew E. Journal: Pigment cell & melanoma research Issue: Volume 30:Number 5(2017) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. "If you want to go far, go together". (September 2017) Authors: Aplin, Andrew E. Journal: Pigment cell & melanoma research Issue: Volume 30:Number 5(2017) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 'TWIST and switch' metastasis. (16th December 2013) Authors: Roesch, Alexander Journal: Pigment cell & melanoma research Issue: Volume 27:Number 2(2014:Mar.) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab. Issue 2 (April 2019) Authors: Sachpekidis, Christos; Kopp-Schneider, Annette; Hakim-Meibodi, Lara; Dimitrakopoulou-Strauss, Antonia; Hassel, Jessica C. Journal: Melanoma research Issue: Volume 29:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 18th Meeting of the European Society for Pigment Cell Research Lisbon, Portugal | 9–12 September 2013. (23rd August 2013) Journal: Pigment cell & melanoma research Issue: Volume 26:Number 5(2013:Sep.) Page Start: E1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 19th International Congress of the Society for Melanoma Research. (29th December 2022) Journal: Pigment cell & melanoma research Issue: Volume 36:Number 1(2023) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas. Issue 3 (June 2020) Authors: Bellocq, David; Roy, Pascal; Kodjikian, Laurent; Mathis, Thibaud; Nguyen, Anh-Minh; Herault, Joël; Rivoire, Michel; Négrier, Sylvie; Thariat, Juliette; Grange, Jean-Daniel Journal: Melanoma research Issue: Volume 30:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2018, Forward, Going Online and all that... (22nd December 2017) Authors: Setaluri, Vijayasaradhi Journal: Pigment cell & melanoma research Issue: Volume 31:Number 1(2018) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2‐phenylethynesulphonamide (PFT‐μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP‐AUY922 in melanoma, by reducing GSH levels. (May 2016) Authors: Yeramian, Andree; Vea, Alvar; Benítez, Sandra; Ribera, Joan; Domingo, Mónica; Santacana, Maria; Martinez, Montserrat; Maiques, Oscar; Valls, Joan; Dolcet, Xavier; Vilella, Ramón; Cabiscol, Elisa; Matias‐Guiu, Xavier; Marti, Rosa M. Journal: Pigment cell & melanoma research Issue: Volume 29:Number 3(2016:May) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case–control analysis. Issue 2 (April 2016) Authors: Wang, Li-E; Li, Chunying; Xiong, Ping; Gershenwald, Jeffrey E.; Prieto, Victor G.; Duvic, Madeleine; Lee, Jeffrey E.; Grimm, Elizabeth A.; Hsu, Tao C.; Wei, Qingyi Journal: Melanoma research Issue: Volume 26:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗